Estradiol and genistein antagonize the ovariectomy effects on skeletal muscle myosin heavy chain expression via ER-β mediated pathways

Journal of Steroid Biochemistry and Molecular Biology

Volumn 120, Issue 1, 2010, Pages 53-59

  Velders, M ^a   Solzbacher, M ^a   Schleipen, B ^a   Laudenbach, U ^a   Fritzemeier, K H ^b   Diel, P ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

17 estradiol; Estrogen; Estrogen receptor selective agonists; Exercise; Genistein; Myosin heavy chain; Phytoestrogens; Skeletal muscle

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR BETA; GENISTEIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTROGEN ACTIVITY; EXERCISE INTENSITY; FEMALE; GASTROCNEMIUS MUSCLE; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; TREADMILL EXERCISE; WISTAR RAT; ANIMAL; METABOLISM; RANDOMIZATION; TIME;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; GENISTEIN; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS;

EID: 77952313101     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.059     Document Type: Article

References (47)

1. Davison S.L., Bell R., Donath S., Montalto J.G., Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clin. Endocrinol. Metab. 2005, 90:3847-3853. [PubMed: 15827095].
2. Meeuwsen I.B., Samson M.M., Verhaar H.J. Evaluation of the applicability of HRT as a preservative of muscle strength in women. Maturitas 2000, 36:49-61. [PubMed: 10989242].
3. Sorensen M.B., Rosenfalck A.M., Hojgaard L., Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes. Res. 2001, 9:622-626. [PubMed: 11595778].
4. Chen Z., Bassford T., Green S.B., Cauley J.A., Jackson R.D., LaCroix A.Z., Leboff M., Stefanick M.L., Margolis K.L. Postmenopausal hormone therapy and body composition-a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am. J. Clin. Nutr. 2005, 82:651-656. [PubMed: 16155280].
5. Hansen R.D., Raja C., Baber R.J., Lieberman D., Allen B.J. Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal women. Acta Diabetol. 2003, 40(Suppl 1):S191-195. [PubMed: 14618470].
6. Kenny A.M., Dawson L., Kleppinger A., Iannuzzi-Sucich M., Judge J.O. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy. J. Gerontol. 2003, 58:M436-440. [PubMed: 12730253].
7. Bemben D.A., Langdon D.B. Relationship between estrogen use and musculoskeletal function in postmenopausal women. Maturitas 2002, 42:119-127. [PubMed: 12065171].
8. Jacobsen D.E., Samson M.M., Kezic S., Verhaar H.J. Postmenopausal HRT and tibolone in relation to muscle strength and body composition. Maturitas 2007, 58:7-18. [PubMed: 17576043].
9. Phillips S.K., Rook K.M., Siddle N.C., Bruce S.A., Woledge R.C. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clinical Science (London) 1993, 84:95-98. [PubMed: 8382141].
10. Moran A.L., Nelson S.A., Landisch R.M., Warren G.L., Lowe D.A. Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice. J. Appl. Physiol.: Respir. Environ. Exercise Physiol. 2007, 102:1387-1393. [PubMed: 17218423].
11. Termin A., Staron R.S., Pette D. Myosin heavy chain isoforms in histochemically defined fiber types of rat muscle. Histochemistry 1989, 92:453-457. [PubMed: 2530196].
12. Pette D., Staron R.S. Myosin isoforms, muscle fiber types, and transitions. Microsc. Res. Tech. 2000, 50:500-509. [PubMed: 10998639].
13. Short K.R., Vittone J.L., Bigelow M.L., Proctor D.N., Coenen-Schimke J.M., Rys P., Nair K.S. Changes in myosin heavy chain mRNA and protein expression in human skeletal muscle with age and endurance exercise training. J. Appl. Physiol.: Respir. Environ. Exercise Physiol. 2005, 99:95-102. [PubMed: 15746299].
14. Kadi F., Karlsson C., Larsson B., Eriksson J., Larval M., Billig H., Jonsdottir I.H. The effects of physical activity and estrogen treatment on rat fast and slow skeletal muscles following ovariectomy. J. Muscle Res. Cell Motil. 2002, 23:335-339. [PubMed: 12630708].
15. Piccone C.M., Brazeau G.A., McCormick K.M. Effect of oestrogen on myofibre size and myosin expression in growing rats. Exp. Physiol. 2005, 90:87-93. [PubMed: 15466459].
16. McCormick K.M., Burns K.L., Piccone C.M., Gosselin L.E., Brazeau G.A. Effects of ovariectomy and estrogen on skeletal muscle function in growing rats. J. Muscle Res. Cell Motil. 2004, 25:21-27. [PubMed: 15160484].
17. Brown M., Foley A., Ferreria J.A. Ovariectomy, hindlimb unweighting, and recovery effects on skeletal muscle in adult rats. Aviat Space Environ. Med. 2005, 76:1012-1018. [PubMed: 16990367].
18. McClung J.M., Davis J.M., Carson J.A. Ovarian hormone status and skeletal muscle inflammation during recovery from disuse in rats. Exp. Physiol. 2007, 92:219-232. [PubMed: 15827095].
19. McClung J.M., Davis J.M., Wilson M.A., Goldsmith E.C., Carson J.A. Estrogen status and skeletal muscle recovery from disuse atrophy. J. Appl. Physiol.: Respir. Environ. Exercise Physiol. 2006, 100:2012-2023. [PubMed: 16497837].
20. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427. [PubMed: 12927427].
21. Marsden J. Hormone-replacement therapy and breast cancer. Lancet Oncol. 2002, 3:303-311. [PubMed: 12067808].
22. Marsden J. The menopause, hormone replacement therapy and breast cancer. J. Steroid Biochem. Mol. Biol. 2002, 83:123-132. [PubMed: 12650709].
23. Katzenellenbogen B.S., Choi I., Delage-Mourroux R., Ediger T.R., Martini P.G., Montano M., Sun J., Weis K., Katzenellenbogen J.A. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J. Steroid Biochem. Mol. Biol. 2000, 74:279-285. [PubMed: 11162936].
24. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv. 2003, 3:281-292. [PubMed: 14993442].
25. Green S. Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens. J. Steroid Biochem. Mol. Biol. 1990, 37:747-751. [PubMed: 2285586].
26. O'Brien J.E., Peterson T.J., Tong M.H., Lee E.J., Pfaff L.E., Hewitt S.C., Korach K.S., Weiss J., Jameson J.L. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements. J. Biol. Chem. 2006, 281:26683-26692. [PubMed: 16847062].
27. Pike A.C., Brzozowski A.M., Hubbard R.E. A structural biologist's view of the oestrogen receptor. J. Steroid Biochem. Mol. Biol. 2000, 74:261-268. [PubMed: 11162934].
28. Velders M., Legerlotz K., Falconer S.J., Stott N.S., McMahon C.D., Smith H.K. Effect of botulinum toxin A-induced paralysis and exercise training on mechanosensing and signalling gene expression in juvenile rat gastrocnemius muscle. Exp. Physiol. 2008, 93:1273-1283. [PubMed: 18603602].
29. Fritzemeier K.H., Hillisch A., Elger W., Kaufmann U., Kollenkirchen U., Kosemund D., Lindenthal B., Muller G., Muhn P., Nubbemeyer R., Peters O., Siebel P., Hegele-Hartung C. Biological effects of ERalpha- and ERbeta-selective estrogens. Ernst Schering Res. Found Workshop 2004, 127-150. [PubMed: 15827095].
30. Hegele-Hartung C., Siebel P., Peters O., Kosemund D., Muller G., Hillisch A., Walter A., Kraetzschmar J., Fritzemeier K.H. Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:5129-5134. [PubMed: 15037755].
31. Hertrampf T., Ledwig C., Kulling S., Molzberger A., Moller F., Zierau O., Vollmer G., Moors S., Degen G.H., Diel P. Responses of estrogen sensitive tissues in female Wistar rats to pre- and postnatal isoflavone exposure. Toxicol. Lett. 2009, [PubMed: 19733640].
32. Delp M.D., Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J. Appl. Physiol. 1996, 80:261-270. [PubMed: 8847313].
33. Glenmark B., Nilsson M., Gao H., Gustafsson J.A., Dahlman-Wright K., Westerblad H. Difference in skeletal muscle function in males vs. females: role of estrogen receptor-beta. Am. J. Physiol. 2004, 287:E1125-1131. [PubMed: 15280152].
34. Wiik A., Glenmark B., Ekman M., Esbjornsson-Liljedahl M., Johansson O., Bodin K., Enmark E., Jansson E. Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol. Scand. 2003, 179:381-387. [PubMed: 14656376].
35. Moreno M., Ordonez P., Alonso A., Diaz F., Tolivia J., Gonzalez C. Chronic 17beta-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging. Age (Dordr) 2009, [PubMed: 19462258].
36. Ordonez P., Moreno M., Alonso A., Llaneza P., Diaz F., Gonzalez C. 17beta-Estradiol and/or progesterone protect from insulin resistance in STZ-induced diabetic rats. J. Steroid Biochem. Mol. Biol. 2008, 111:287-294. [PubMed: 18657616].
37. D'Eon T.M., Souza S.C., Aronovitz M., Obin M.S., Fried S.K., Greenberg A.S. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 2005, 280:35983-35991. [PubMed: 16109719].
38. Sanchez-Ortiz R.F., Wang Z., Menon C., DiSanto M.E., Wein A.J., Chacko S. Estrogen modulates the expression of myosin heavy chain in detrusor smooth muscle. Am. J. Physiol. Cell Physiol. 2001, 280:C433-440. [PubMed: 11171561].
39. Liu Y., Lormes W., Reissnecker S., Steinacker J.M. Effects of high intensity resistance and low intensity endurance training on myosin heavy chain isoform expression in highly trained rowers. Int. J. Sports Med. 2003, 24:264-270. [PubMed: 12784168].
40. Mendell L.M. The size principle: a rule describing the recruitment of motoneurons. J. Neurophysiol. 2005, 93:3024-3026. [PubMed: 15914463].
41. Gustafsson J.A. ERbeta scientific visions translate to clinical uses. Climacteric 2006, 9:156-160. [PubMed: 16766427].
42. Weihua Z., Saji S., Makinen S., Cheng G., Jensen E.V., Warner M., Gustafsson J.A. Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:5936-5941. [PubMed: 10823946].
43. Strom A., Hartman J., Foster J.S., Kietz S., Wimalasena J., Gustafsson J.A. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:1566-1571. [PubMed: 14745018].
44. Wiik A., Ekman M., Johansson O., Jansson E., Esbjornsson M. Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. Histochem. Cell Biol. 2009, 131:181-189. [PubMed: 18825402].
45. Matsumura K., Tanaka T., Kawashima H., Nakatani T. Involvement of the estrogen receptor beta in genistein-induced expression of p21(waf1/cip1) in PC-3 prostate cancer cells. Anticancer Res. 2008, 28:709-714. [PubMed: 18507011].
46. Qin L., Zhang G., Hung W.Y., Shi Y., Leung K., Yeung H.Y., Leung P. Phytoestrogen-rich herb formula " XLGB" prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats. J. Bone Miner. Metab. 2005, 23(Suppl.):55-61. [PubMed: 15984415].
47. Jeng Y.J., Kochukov M.Y., Watson C.S. Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. J. Mol. Signal. 2009, 4:2. [PubMed: 19400946].